24 results on '"Grover, Shilpa"'
Search Results
2. Screening for Pancreatic Cancer in High-risk Populations
3. Racial variation in frequency and phenotypes of APC and MUTYH mutations in 6,169 individuals undergoing genetic testing
4. Su1275 IMMUNE CHECKPOINT INHIBITOR ESOPHAGITIS: TREATMENT OUTCOMES AND COMPLICATIONS
5. Hereditary Pancreatic Cancer
6. Tu1146 GERMLINE AND SOMATIC VARIANTS ASSOCIATED WITH IMMUNE-CHECKPOINT INHIBITOR RELATED COLITIS
7. Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients
8. Tu1172: CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR GASTRITIS IN PATIENTS WITH CANCER
9. Su1249: CANCER OUTCOMES IN PATIENTS TREATED WITH BIOLOGICS FOR THE TREATMENT OF STEROID-REFRACTORY IMMUNE CHECKPOINT INHIBITOR COLITIS
10. Su1246: PREDICTORS OF NEED FOR BIOLOGIC THERAPY IN IMMUNE CHECKPOINT INHIBITOR COLITIS
11. 236 EFFECT OF CORTICOSTEROID DOSING ON OUTCOMES IN HIGH-GRADE IMMUNE CHECKPOINT INHIBITOR HEPATITIS
12. 235 LIVER BIOPSY IS OF LIMITED UTILITY IN THE DIAGNOSIS AND MANAGEMENT OF IMMUNE CHECKPOINT INHIBITOR HEPATITIS IN CANCER PATIENTS
13. Sa284 ETIOLOGY AND OUTCOMES OF PANCREATIC ENZYME ELEVATIONS WITH THE USE OF IMMUNE CHECKPOINT INHIBITORS IN ADVANCED CANCERS
14. Esophagitis dissecans superficialis with immune checkpoint inhibitor therapy
15. Checkpoint inhibitor induced esophagitis with documented resolution on infliximab
16. Su1188 ABDOMINAL CT SHOULD NOT BE USED TO SCREEN FOR IMMUNE CHECKPOINT INHIBITOR COLITIS
17. Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS
18. Su1949 Comparison of Pathogenic APC and Biallelic MUTYH Mutations Between Ashkenazi Jews and Non-Ashkenazi Jews With Colorectal Adenomas
19. S1983 Phenotypic Differences Between APC and Biallelic MUTYH Mutation Carriers in 1193 Individuals With Attenuated Polyposis
20. M1935 Premm1,2 and Barnetson-MMRpredict Risk Models Have High Sensitivity for Identifying Individuals with Lynch Syndrome
21. M1928 Prevalence of APC and MYH Mutations Among 2141 Individuals with Greater Than 10 Colorectal Adenomas
22. Physician awareness of cancer screening recommendations for hereditary nonpolyposis colorectal cancer (HNPCC) is limited
23. Predictors of an accurate family history assessment in colorectal cancer patients
24. Referral rates are low for genetic evaluation in patients meeting bethesda guidelines for HNPCC
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.